Prevalence of Smqnr and plasmid-mediated quinolone resistance determinants in clinical isolates of Stenotrophomonas maltophilia from Japan: novel variants of Smqnr.

PubWeight™: 0.75^‹?›

🔗 View Article (PMC 4475831)

Published in New Microbes New Infect on May 14, 2015

Authors

H Kanamori¹, H Yano², A Tanouchi², R Kakuta², S Endo², S Ichimura³, M Ogawa³, M Shimojima³, S Inomata², D Ozawa², T Aoyagi², D J Weber⁴, M Kaku²

Author Affiliations

1: Department of Infection Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan ; Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, United States.
2: Department of Infection Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
3: Department of Bacteriology, BML Inc., Kawagoe, Saitama, Japan.
4: Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, United States.

Articles cited by this ↗

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05

Quinolone resistance from a transferable plasmid. Lancet (1998) 11.28

The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis (2006) 7.20

Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev (2009) 4.43

Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev (2012) 4.39

Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents (2010) 3.77

qnr Gene nomenclature. Antimicrob Agents Chemother (2008) 2.81

Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother (2008) 2.70

Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis (2009) 2.61

Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents (2005) 1.90

Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol (2008) 1.59

Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen. J Hosp Infect (2004) 1.43

Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2008) 1.18

Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg? J Antimicrob Chemother (1998) 1.12

SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2009) 1.09

Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother (2010) 0.95

Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model. Antimicrob Agents Chemother (2004) 0.90

Two new variants of and creation of a repository for Stenotrophomonas maltophilia quinolone protection protein (Smqnr) genes. Int J Antimicrob Agents (2010) 0.88

Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection. Eur Respir J (2005) 0.87

Detection of the Smqnr quinolone protection gene and its prevalence in clinical isolates of Stenotrophomonas maltophilia in China. J Med Microbiol (2011) 0.86

Articles by these authors ⇆

Clinical and molecular epidemiological features of tuberculosis after the 2011 Japan earthquake and tsunami. Int J Tuberc Lung Dis (2016) 0.75